Melanoma Journal Articles for September 2020
New England Journal of Medicine
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
Reinhard Dummer, M.D., Axel Hauschild, M.D., Mario Santinami, M.D., Victoria Atkinson, M.D., Mario Mandalà, M.D., John M. Kirkwood, M.D., Vanna Chiarion Sileni, M.D., James Larkin, M.D., Ph.D., Marta Nyakas, M.D., Caroline Dutriaux, M.D., Andrew Haydon, M.B., B.S., Ph.D., Caroline Robert, M.D., Ph.D., et al.
September 2, 2020
DOI: 10.1056/NEJMoa2005493
Cancer Discovery
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Gretchen M. Alicea, Vito W. Rebecca, Aaron R. Goldman, Mitchell E. Fane, Stephen M. Douglass, Reeti Behera, Marie R. Webster, Curtis H. Kugel III, Brett L. Ecker, M. Cecilia Caino, Andrew V. Kossenkov, Hsin-Yao Tang, Dennie T. Frederick, Keith T. Flaherty, Xiaowei Xu, Qin Liu, Dmitry I. Gabrilovich, Meenhard Herlyn, Ian A. Blair, Zachary T. Schug, David W. Speicher and Ashani T. Weeraratna
DOI: 10.1158/2159-8290.CD-20-0329 Published September 2020
JAAD
A retrospective multicenter study of fatal pediatric melanoma
Elena B. Hawryluk, MD, PhD, Danna Moustafa, BS, Diana Bartenstein, MD, Zachary Wolner, MD, Jennifer Huang, MD, Ashfaq A. Marghoob, MD, et.al.
Published: July 01, 2020DOI:https://doi.org/10.1016/j.jaad.2020.06.1010
JAAD
Survival in patients with multiple primary melanomas: Systematic review and meta-analysis
Genevieve Peek, MBBS, Catherine M. Olsen, PhD, Peter Baade, PhD, Danny R. Youlden, PhD, Joanne F. Aitken, PhD, Adele C. Green, MBBS, PhD, Kiarash Khosrotehrani, MD, PhD
Published:April 01, 2020DOI:https://doi.org/10.1016/j.jaad.2020.03.076
MDPI _ Cancers
Targeted Therapies for Melanoma
by Karel Smetana, Jr. 1,2,*,Lukáš Lacina 1,2,3 andOnd?ej Kodet 1,2,3
Cancers 2020, 12(9), 2494; https://doi.org/10.3390/cancers12092494
Received: 31 August 2020 / Accepted: 1 September 2020 / Published: 3 September 2020
Molecular and Clinical Oncology
Primary acral amelanotic melanoma: A rare case report
Jiaojiao Zhang, Huizhi Yang, Jiaxi Lin, Fang Zhang, Jianqiang Shi, Rongyi Chen
Published online on: September 3, 2020 https://doi.org/10.3892/mco.2020.2129
Oncology
Management of Melanoma during Pregnancy: A Case Series of 11 Women Treated at NYU Langone HealthSawyers A.E.a,b · Pavlick A.C.a,b,c · Weber J.S.a,c · Osman I.a,b,c · Stein J.A.a,b
|
https://doi.org/10.1159/000506811
Dermatologic Therapy
Gender differences in cutaneous melanoma: Demographics, prognostic factors, and survival outcomes
Sara Behbahani Spandana Maddukuri Joshua B. Cadwell W. Clark Lambert Robert A. Schwartz
First published: 05 August 2020 https://doi.org/10.1111/dth.14131
European Journal of Radiology
Available online 8 September 2020, 109268
Value of MR-based radiomics in differentiating uveal melanoma from other intraocular masses in adults
YapingSuabXiaolinXubcdPanliZuoeYuweiXiaeXiaoxiaQuabQinghuaChenabJianGuoabWenbinWeibcdJunfangXianab
https://doi.org/10.1016/j.ejrad.2020.109268
Cancer epidemiology, biomarkers & prevention
Disparities in the Occurrence of Late Effects Following Treatment among Adolescent and Young Adult Melanoma Survivors
Alicia A. Gingrich, Candice A.M. Sauder, Melanie Goldfarb, Qian Li, Ted Wun and Theresa H.M. Keegan
DOI: 10.1158/1055-9965.EPI-20-0427
International Journal of Molecular Sciences
Evaluation of Radioiodinated Fluoronicotinamide/ Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma
Chao-Cheng Chen 1,† , Yang-Yi Chen 1,† , Yi-Hsuan Lo 1 , Ming-Hsien Lin 2,3, Chih-Hsien Chang 1,4 , Chuan-Lin Chen 1 , Hsin-Ell Wang 1 and Chun-Yi Wu 1,*
Received: 24 August 2020; Accepted: 3 September 2020; Published: 9 September 2020
Int. J. Mol. Sci. 2020, 21, 6597; doi:10.3390/ijms21186597
British Journal of Dermatology
Occupation and cutaneous melanoma: a 45?year historical cohort study of 14·9 million people in five Nordic countries
J.H. Alfonso, J.I. Martinsen, E. Weiderpass, E. Pukkala, K. Kjærheim, L. Tryggvadottir, E Lynge
First published: 06 July 2020
https://doi.org/10.1111/bjd.19379
JAMA Dermatology
July 15, 2020
Association of Anti–Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma
Angélique Brunot, MD1; Jean-Jacques Grob, MD, PhD2; Geraldine Jeudy, MD3; et alFlorent Grange, MD, PhD4; Bernard Guillot, MD, PhD5; Nora Kramkimel, MD6; Laurent Mortier, MD, PhD7; Yannick Le Corre, MD8; François F. Aubin, MD, PhD9; Sandrine Mansard, MD10; Céleste Lebbé, MD, PhD11; Astrid Blom, MD, PhD12; Henri Montaudie, MD13; Damien Giacchero, MD14; Sorilla Prey, MD15; Delphine Legoupil, MD16; Alexis Guyot, MD17; Mona Amini-adle, MD18; Florence Granel-Brocard, MD19; Nicolas Meyer, MD20; Monica Dinulescu, MD21; Julien Edeline, MD, PhD1; Boris Campillo-Gimenez, MD1; Thierry Lesimple, MD, MSc1
JAMA Dermatol. 2020;156(9):982-986. doi:10.1001/jamadermatol.2020.2149
BMC Bioinformatics
Review of medical image recognition technologies to detect melanomas using neural networks
Mila Efimenko, Alexander Ignatev & Konstantin Koshechkin
BMC Bioinformatics volume 21, Article number: 270 (2020)
Cancer Immunology, Immunotherapy
Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma
Cancer Immunology, Immunotherapy (2020) Published: 14 September 2020
Clinical Cancer Research
Chloroquine sensitizes GNAQ/11-mutated melanoma to MEK1/2 inhibition
Amanda Truong, Jae Hyuk Yoo, Michael Scherzer, John Michael S Sanchez, Kali J Dale, Conan G Kinsey, Jackson R Richards, Donghan Shin, Phaedra Ghazi, Michael D. Onken, Kendall J Blumer, Shannon J. Odelberg and Martin McMahon
DOI: 10.1158/1078-0432.CCR-20-1675
BioRxiv
Podoplanin drives dedifferentiation and amoeboid invasion of melanoma
Charlotte M de Winde, Samantha L George, Abbey Arp, Agnesska C Benjamin, Eva Crosas-Molist, Yukti Hari-Gupta, Alexander Carver, Valerio Imperatore, Victor G Martinez, Victoria Sanz-Moreno, Sophie E Acton
doi: https://doi.org/10.1101/2020.07.23.218578
Clinical Cancer Research
Chloroquine sensitizes GNAQ/11-mutated melanoma to MEK1/2 inhibition
Amanda Truong, Jae Hyuk Yoo, Michael Scherzer, John Michael S Sanchez, Kali J Dale, Conan G Kinsey, Jackson R Richards, Donghan Shin, Phaedra Ghazi, Michael D. Onken, Kendall J Blumer, Shannon J. Odelberg and Martin McMahon
DOI: 10.1158/1078-0432.CCR-20-1675 September 15, 2020
BioRix
Podoplanin drives dedifferentiation and amoeboid invasion of melanoma
Charlotte M. de Winde, Samantha L. George, Abbey B. Arp, Agnesska C. Benjamin, Eva Crosas-Molist, Yukti Hari-Gupta, Alexander Carver, Valerio Imperatore, Victor G. Martinez, Victoria Sanz-Moreno, Sophie E. Acton
doi: https://doi.org/10.1101/2020.07.23.218578 Posted September 14, 2020.
MDPI – Life
Treatment of Advanced Melanoma: Past, Present and Future
Taku Fujimura, Yumi Kambayashi, Kentaro Ohuchi, Yusuke Muto and Setsuya Aiba
Received: 2 September 2020; Accepted: 13 September 2020; Published: 16 September 2020
Life 2020, 10, 208; doi:10.3390/life10090208
Cureus
Primary Vaginal Malignant Melanoma: A Case Report and Review of Literature
Mahati Paravathaneni, Vinay Edlukudige Keshava, Bohdan Baralo, Rajesh Thirumar
Published: September 18, 2020 (see history)
DOI: 10.7759/cureus.10536
The lancet
Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Prof Paolo A Ascierto, MD , Michele Del Vecchio, MD, Mario Mandalá, MD, Prof Helen Gogas, MD, Ana M Arance, MD, Prof Stephane Dalle, MD, et al.
Published:September 19, 2020 DOI:https://doi.org/10.1016/S1470-2045(20)30494-0
Theranostics 2020; 10(25):11428-11443. doi:10.7150/thno.47432
Research Paper
BET inhibitor suppresses melanoma progression via the noncanonical NF-?B/SPP1 pathway
Guangtong Deng1,2*, Furong Zeng1,2*, Juan Su1,2, Shuang Zhao1,2, Rui Hu1,2, Wu Zhu1,2, Shuo Hu3, Xiang Chen1,2?, Mingzhu Yin1,2?
Histopathology
Comprehensive clinicopathological and molecular analysis of primary malignant melanoma of the oesophagus
Sho Tsuyama Shinji Kohsaka Takuo Hayashi Yoshiyuki Suehara Takashi Hashimoto Yoshiaki Kajiyama Masahiko Tsurumaru Toshihide Ueno … See all authors
First published: 11 July 2020
https://doi.org/10.1111/his.14210
Clinical Cancer Research
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma
Mark R. Middleton, Cheryl McAlpine, Victoria K. Woodcock, Pippa Corrie, Jeffrey R. Infante, Neil M. Steven, Thomas R Jeffry Evans, Alan Anthoney, Alexander N. Shoushtari, Omid Hamid, Avinash Gupta, Antonella Vardeu, Emma Leach, Revashnee Naidoo, Sarah Stanhope, Sion Lewis, Jacob Hurst, Ita O’Kelly and Mario Sznol
DOI: 10.1158/1078-0432.CCR-20-1247
Cancer Research
BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM
Mirella Belleri, Giuseppe Paganini, Daniela Coltrini, Roberto Ronca, Daniela Zizioli, Michela Corsini, Andrea Barbieri, Elisabetta Grillo, Stefano Calza, Roberto Bresciani, Eugenio Maiorano, Mauro G. Mastropasqua, Tiziana Annese, Arianna Giacomini, Domenico Ribatti, Josefina Casas, Thierry Levade, Gemma Fabrias and Marco Presta
DOI: 10.1158/0008-5472.CAN-19-3382
This OnlineFirst version was published on September 30, 2020